| Metric | Value (₹ Cr) | Q1 FY26 | Q2 FY25 |
|---|---|---|---|
| Revenue | 51.00 | 5.2% | 15.8% |
| Total Income | 51.29 | 5.7% | 16.1% |
| Expenditure | 48.62 | 6.9% | 11.9% |
| PBT | 2.67 | 23.5% | 257.9% |
| Net Profit | 1.16 | 17.7% | 56.2% |
| OPM | 10.06% | 1.82pp | 15.08pp |
| NPM | 2.25% | 0.33pp | 0.58pp |
| EPS | 1.19 | 17.9% | 28.0% |
Everest Organics Q2 FY 2025-26 Financial Results Reveal Profit Growth and Increased Sales
12 Nov 2025 · 12 Nov 2025, 07:55 pm
Summary
Everest Organics Ltd has reported a profit growth and increased sales in its Q2 FY 2025-26 financial results. The company's revenue and profitability have shown positive trends. The management comments are optimistic, highlighting the company's growth and future prospects.
Key Highlights
- 1
Q2 FY 2025-26 financial results
- 2
Profit growth
- 3
Increased sales
- 4
Positive trends in revenue and profitability
- 5
Optimistic management comments
Management Comments
Shweta Singh
The meeting commenced at 03:30 PM and concluded at 05:35 P.M.
Dr.S K.SIRISHA
The Company Operates in only one reportable business segment, that is Active Pharmaceutical Ingredients (API1) and their Intermediates.
Informational and educational content only. Not investment advice.